The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
Automakers are interested in solid-state batteries (SSBs) because they’re smaller, lighter, and safer than the lithium-ion solutions in current electric cars. A solid-state battery is a ...
Ono Pharmaceutical subsidiary Deciphera Pharmaceuticals has dropped an early-stage candidate for advanced cancers from its pipeline. DCC-3084, a pan-RAF inhibitor, “is no longer in our pipeline and we ...
For years, Toyota has talked up the promise of solid-state batteries for EVs. Now, that long-running effort is inching toward something tangible. Late last week, Japanese oil refiner Idemitsu Kosan, ...
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma The recommended Phase ...
VS-7375 shows promising safety and antitumor activity in KRAS G12D-mutated solid tumors, with no dose-limiting toxicities at 400 mg and 600 mg daily doses. 80% of efficacy-evaluable patients ...
First presentation of clinical data from the sixth DXd antibody drug conjugate from the oncology pipeline of Daiichi Sankyo Early results support continued development of DS-3939, a potential first-in ...
WASHINGTON — The Pentagon on Sept. 26 announced three contracts aimed at beefing up U.S. production of solid rocket motors (SRMs), a part of the defense industrial base officials say is vulnerable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results